U.S. Markets open in 8 hrs 30 mins

TransMedics Group, Inc. (TMDX)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
31.29-0.86 (-2.67%)
At close: 04:00PM EDT
31.25 -0.04 (-0.13%)
After hours: 07:58PM EDT
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close32.15
Bid0.00 x 1400
Ask0.00 x 800
Day's Range31.26 - 34.20
52 Week Range10.00 - 35.37
Avg. Volume269,766
Market Cap868.87M
Beta (5Y Monthly)1.72
PE Ratio (TTM)N/A
EPS (TTM)-1.38
Earnings DateFeb 28, 2022 - Mar 04, 2022
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est36.50
  • Motley Fool

    Up 1,000% in 5 Years? Here Are 3 Stocks That Can Run That High

    Suppose you invest in all three of these healthcare companies, and two of them go belly up. Here are our selections for biotech stocks that can run up 1,000% by 2027. George Budwell (Intellia Therapeutics): If you're on the hunt for a stock that can produce life-changing gains over the next five years, the beaten-down biotech industry is definitely a good place to start your search.

  • Simply Wall St.

    Is TransMedics Group (NASDAQ:TMDX) A Risky Investment?

    Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...

  • PR Newswire

    TransMedics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

    TransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart, and liver failure, today announced that on June 1, 2022, TransMedics granted non-qualified stock options to purchase an aggregate of 35,000 shares of its common stock to three employees as a material inducement for each employee's entry into employment with TransMedics. The options were approved by the Compensation Committee o